Notice2024-19053
Meeting of the National Vaccine Advisory Committee
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
August 26, 2024
Issuing agencies
Health and Human Services Department
Abstract
As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) hereby gives notice that the National Vaccine Advisory Committee (NVAC) will hold an in-person meeting. The meeting will be open to the public and public comment will be heard during the meeting.
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 165 (Monday, August 26, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 165 (Monday, August 26, 2024)]
[Notices]
[Page 68447]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-19053]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meeting of the National Vaccine Advisory Committee
AGENCY: Office of Infectious Disease and HIV/AIDS Policy, Office of the
Assistant Secretary for Health, Office of the Secretary, Department of
Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: As stipulated by the Federal Advisory Committee Act, the
Department of Health and Human Services (HHS) hereby gives notice that
the National Vaccine Advisory Committee (NVAC) will hold an in-person
meeting. The meeting will be open to the public and public comment will
be heard during the meeting.
DATES: The meeting will be held September 12-13, 2024. The confirmed
meeting times and agenda will be posted on the NVAC website at <a href="http://www.hhs.gov/nvpo/nvac/meetings/index.html">http://www.hhs.gov/nvpo/nvac/meetings/index.html</a> as soon as they become
available.
ADDRESSES: Instructions regarding attending this meeting will be posted
online at: <a href="http://www.hhs.gov/nvpo/nvac/meetings/index.html">http://www.hhs.gov/nvpo/nvac/meetings/index.html</a> at least
one week prior to the meeting. Pre-registration is required for those
who wish to attend the meeting in person or participate in public
comment. Please register at <a href="http://www.hhs.gov/nvpo/nvac/meetings/index.html">http://www.hhs.gov/nvpo/nvac/meetings/index.html</a>.
FOR FURTHER INFORMATION CONTACT: Ann Aikin, Acting Designated Federal
Officer, Office of Infectious Disease and HIV/AIDS Policy, U.S.
Department of Health and Human Services, Tower Building, Room, 1101
Wootton Parkway, Rockville, MD 20852. Email: <a href="/cdn-cgi/l/email-protection#1678607775567e7e6538717960"><span class="__cf_email__" data-cfemail="2749514644674f4f5409404851">[email protected]</span></a>. Phone: 202-
795-7697.
SUPPLEMENTARY INFORMATION: Pursuant to section 2101 of the Public
Health Service Act (42 U.S.C. 300aa-1), the Secretary of HHS was
mandated to establish the National Vaccine Program to achieve optimal
prevention of human infectious diseases through immunization and to
achieve optimal prevention against adverse reactions to vaccines. The
NVAC was established to provide advice and make recommendations to the
Director of the National Vaccine Program on matters related to the
Program's responsibilities. The Assistant Secretary for Health serves
as Director of the National Vaccine Program.
During this meeting, the NVAC will hear presentations about
implementation of the universal hepatitis B vaccine recommendations of
adults aged 19-59 years and adults aged 60 years and older with risk
factors for hepatitis B infection, new approaches for tuberculosis
vaccine innovation, and research to inform future HIV vaccine
development. The NVAC will also host panels on vaccine equity, provider
payment, and planning for the development of the next national vaccine
strategy.
Please note that agenda items are subject to change, as priorities
dictate. Information on the final meeting agenda will be posted prior
to the meeting on the NVAC website: <a href="http://www.hhs.gov/nvpo/nvac/index.html">http://www.hhs.gov/nvpo/nvac/index.html</a>.
Members of the public will have the opportunity to provide comment
at the NVAC meeting during the public comment period designated on the
agenda. Public comments made during the meeting will be limited to
three minutes per person to ensure time is allotted for all those
wishing to speak. Members of the public may also submit written
comments. Written comments should not exceed three pages in length.
Individuals planning to submit comments should email their written
comments or their request to provide a comment during the meeting to
<a href="/cdn-cgi/l/email-protection#a9c7dfc8cae9c1c1da87cec6df"><span class="__cf_email__" data-cfemail="6d031b0c0e2d05051e430a021b">[email protected]</span></a> at least five business days prior to the meeting.
Dated: August 19, 2024.
Ann Aikin,
Acting Designated Federal Official, Office of the Assistant Secretary
for Health.
[FR Doc. 2024-19053 Filed 8-23-24; 8:45 am]
BILLING CODE 4150-44-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on August 26, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.